New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2013
14:38 EDTAKRXAkorn expects U.S. FDA inspection of India site by late 2015, early 2016
As a first step, we have implemented Akorn's global quality policies at the Akorn India site. We are now in the process of implementing our plan to transfer existing or file new products to trigger U.S. FDA facility inspections by late 2013 or early 2014. The proposed oncology facility and expanded injectable facility should be completed by late 2014, and we expect the U.S. FDA to inspect these facilities by late 2015 or early 2016.
News For AKRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 20, 2015
08:09 EDTAKRXAkorn price target raised to $49 from $44 at Jefferies
Jefferies raised its price target for Akorn shares to $49 to reflect its FY15 estimates. The firm keeps a Buy rating on the stock.
07:11 EDTAKRXAkorn receives FDA approval for Phenylephrine Hydrochloride Ophthalmic Solution
Subscribe for More Information
January 15, 2015
17:36 EDTAKRXAkorn's generic Durezol patent challenged
Subscribe for More Information
January 12, 2015
17:14 EDTAKRXOak Ridge Investments reports 4.03% passive stake in Akorn

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use